By vgreene, 5 February, 2020 See interim guidance for implementing home care of pts not requiring hospitalization
By vgreene, 5 February, 2020 Decide in-pt vs out-pt care on case-by-case basis. Decision depends not only on clinical presentation, but also on pt’s ability to engage in monitoring and risk of transmission in pt’s home environment
By vgreene, 5 February, 2020 Possible risk factors for progressing to severe illness may include, but are not limited to, older age, and underlying chronic medical conditions such as lung dz, cancer, heart failure, cerebrovascular dz, renal dz, liver dz, diabetes, immunocompromising
By vgreene, 5 February, 2020 Pts w/ mild clinical presentation may not initially require hospitalization. However, clinical s/sx may worsen w/ progression to lower resp tract dz in 2nd wk of illness; monitor all pts closely
By vgreene, 5 February, 2020 For more info, see: WHO interim guidance on clinical mgmt of severe acute resp infxn when nCoV infxn is suspected
By vgreene, 5 February, 2020 For more info, see: WHO interim guidance on clinical mgmt of severe acute resp infxn when nCoV infxn is suspected
By vgreene, 5 February, 2020 Avoid corticosteroids unless indicated for other reasons (eg, COPD exacerbation or septic shock), because of the potential for prolonging viral replication as observed in MERS-CoV pts
By vgreene, 5 February, 2020 Healthcare personnel should care for pts in Airborne Infection Isolation Room (AIIR). Use Standard Precautions, Contact Precautions, and Airborne Precautions and eye protection
By vgreene, 5 February, 2020 Clinical mgmt includes prompt implementation of recommended infxn prevention and control measures and supportive mgmt of complications, incl advanced organ support if indicated